Bio-Rad Laboratories (BIO) EBITDA
Market Cap: $6.81B
Avg Volume: 360.08K
Industry: Medical - Devices
Sector: Healthcare
What is Bio-Rad Laboratories's EBITDA?
- Bio-Rad Laboratories's annual EBITDA is $-2.14B.
- Bio-Rad Laboratories's quarterly EBITDA is $58.40M.
What is EBITDA?
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.
How is EBITDA calculated?
EBITDA is calculated using the following formula:
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
Related Metrics
Other important metrics to assess Bio-Rad Laboratories's financial health include:
- EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
- Annual: -83.46%
- Quarterly: 8.75%
- Growth EBITDA - measures the annual growth rate of the company's EBITDA:
- Annual: -252.15%
- Quarterly: -93.67%
- Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
- Annual: -266.52%
- Quarterly: -93.84%
These metrics provide insights into Bio-Rad Laboratories's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual EBITDA
$-2.14B
Quarterly EBITDA
$58.40M
Bio-Rad Laboratories Historical EBITDA
Historical EBITDA Ratio (Annual)
Historical EBITDA Ratio (Quarterly)
Bio-Rad Laboratories Historical EBITDA Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | EBITDA | Growth EBITDA | EBITDA Ratio | Growth EBITDA Ratio |
|---|---|---|---|---|
| 2024 | $-2.14B | -252.15% | -83.46% | -266.52% |
| 2023 | $-608.26M | 86.45% | -22.77% | 85.79% |
| 2022 | $-4.49B | -179.77% | -160.19% | -183.19% |
| 2021 | $5.63B | 10.24% | 192.55% | -3.98% |
| 2020 | $5.10B | 107.59% | 200.53% | 88.51% |
| 2019 | $2.46B | 264.45% | 106.37% | 261.05% |
| 2018 | $674.72M | 150.34% | 29.46% | 136.14% |
| 2017 | $269.52M | 30.58% | 12.48% | 25.02% |
| 2016 | $206.40M | -31.05% | 9.98% | -32.67% |
| 2015 | $299.34M | -1.40% | 14.82% | 6.20% |
Related Metrics
Explore detailed financial metrics and analysis for BIO.